Cargando…
Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial
BACKGROUND: Gouty arthritis (GA) is a chronic systemic disease with recurrent acute monoarthritis. In a previous study, a higher incidence of acute flares was observed during the initial marked decrease in serum urate level. Our study evaluated the effect of early urate-lowering therapy in patients...
Autores principales: | Yang, Deng-Ho, Chen, Hsiang-Cheng, Wei, James Cheng-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817311/ https://www.ncbi.nlm.nih.gov/pubmed/36609359 http://dx.doi.org/10.1186/s40001-022-00982-8 |
Ejemplares similares
-
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
por: Cabău, Georgiana, et al.
Publicado: (2019) -
Cynarin suppresses gouty arthritis induced by monosodium urate crystals
por: Wu, Changgui, et al.
Publicado: (2022) -
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
por: Schlesinger, Naomi, et al.
Publicado: (2011) -
Impact of the Synbiotics and Urate-Lowering Therapy on Gut Microbiota and Cytokine Profile in Patients with Chronic Gouty Arthritis
por: Kondratiuk, Vitalii Evgenovich, et al.
Publicado: (2020) -
Ameliorative Effects of Cardamonin on Monosodium Urate-Induced Gouty Arthritis through Inhibiting NLRP3 Inflammasome Mediation
por: Wang, Chih-Chien, et al.
Publicado: (2021)